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Background
Human cells may respond to viral infection or other
stress by expressing on their membrane ligands for
activating receptors present on cytotoxic NK and T
cells, such as NKG2D and DNAM-1 receptors, thus
eliciting recognition and elimination by the immune
system. Work from our laboratory has shown that,
upon infection with HIV-1, CD4+ T cells over-express
ligands for NKG2D (MICA/B and ULBP2) and
DNAM-1 (PVR), hence becoming susceptible to
NKG2D-and DNAM-1-mediated lysis by NK cells. The
cell-surface expression of activating ligands, however,
is down-regulated by the HIV-1 Nef and Vpu proteins,
a phenomenon that protects infected cells from cyto-
toxic responses to some extent. Here we further inves-
tigated the dual regulation of activating ligands by
HIV-1 focusing on viral and cellular factors involved in
up-regulation of ligands expression and on the capacity
of HIV-infected cells to release soluble ligands in the
extracellular environment.
Materials and methods
Jurkat T cells and primary CD4+ T lymphocytes were
transduced with HIV-1 or individual viral genes (wt or
mutated). Ligands expression was analyzed by measuring
mRNA, cell-surface and total protein levels. Activation
of the DNA Damage Response (DDR) pathway and cell
cycle profile were also analyzed. Soluble ligands were
measured by ELISA in the medium of in vitro infected
cells as well as in the plasma of HIV-infected patients.
The impact of soluble ligands on the expression and
function of their cognate receptor was investigated by
FACS-based immunofluorescence analysis and cytotoxi-
city assays.
Results
Results showed that the HIV-1 Vpr protein increases
cell-surface and total PVR levels acting at a post-tran-
scriptional level. As reported previously for NKG2D
ligands, PVR was up-regulated by Vpr via activation of
the ATR kinase that triggers the DDR pathway and G2
arrest. Increased expression of PVR and NKG2D ligands
correlated with their higher release in HIV-infected T
cell cultures. Moreover, treatment-naïve HIV-infected
patients displayed increased plasma levels of soluble
MICA and ULBP2 and reduced NKG2D expression on
NK and CD8+ T cells. However, uptake of antiretroviral
therapy (ART) resulted in the drop of soluble NKG2D
ligands and recovery of NKG2D expression. Finally, we
found that NKG2D ligands in patients’ plasma down-
regulated NKG2D on NK and CD8+ T cells and
impaired NKG2D-mediated cytotoxicity of NK cells.
Conclusions
Attempts to boost the DDR-mediated up-regulation of
NKG2D and DNAM-1 ligands represent novel attractive
approaches to improve recognition and elimination of
HIV-infected cells by the immune system. By promoting
the release of soluble ligands, HIV-1 may simultaneously
attenuate their expression on infected cells and down-
regulate cognate receptors on effector cells, thus sub-
verting immuno-surveillance against HIV-1 and oppor-
tunistic infections, but ART has the potential to avoid
such immune dysfunction.
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